Yongin, South Korea

Joseph Kim

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignees: Je Ii Pharmaceutical Co., Ltd., Je Il Pharmaceutical Co., Ltd., Wellmarker Bio Co., Ltd.. Active years: 2020-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph Kim. Retrieved from https://idiyas.com/inventor/joseph-kim-end855lp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0



Average Co-Inventor Count = 8.7

ph-index = 1


Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Journey of Joseph Kim

Introduction: Joseph Kim is a visionary inventor hailing from Yongin-si, South Korea, known for his groundbreaking contributions to various industries.

Latest Patents: Joseph Kim holds several patents in the fields of technology and healthcare, showcasing his versatility and ingenuity in creating solutions for complex problems.

Career Highlights: With a career spanning over two decades, Joseph Kim has worked with top research institutions and companies, leading teams to develop cutting-edge technologies that have revolutionized the way we live and work.

Collaborations: Throughout his career, Joseph Kim has collaborated with renowned inventors, patent attorneys, and industry experts, fostering a culture of innovation and excellence in all his projects.

Conclusion: Joseph Kim's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs, leaving a lasting impact on the world.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…